The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended follow-up (6 years) of the phase 2 LITESPARK-004 study of belzutifan in participants with von Hippel-Lindau disease–associated neoplasms.
 
Ramaprasad Srinivasan
Research Funding - Allogene Therapeutics (Inst); Allogene Therapeutics (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/Astellas; Regeneron; Sanofi; Terns Pharmaceuticals; Xencor
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - US Patent No. 18/708,529
Travel, Accommodations, Expenses - Eisai; Exelixis; Pfizer
 
Othon Iliopoulos
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - MGH 02363—Small molecule inhibitors of hypoxia inducible-factor as anti-angiogenic compounds Issued patents: 8,691,866 and 9,604,958 Pending US patent applications: 15/431,967 (PCT application number: PCT/US09/067555); MGH 21488—Metabolic gene, enzyme, and flux targets for cancer therapy Issued patent: 10,064,885
Travel, Accommodations, Expenses - Merck
 
Kathryn Beckermann
Consulting or Advisory Role - Adicet Bio; Aravive; Arcus Biosciences; AstraZeneca; AVEO; Bristol-Myers Squibb; Eisai; Exelixis; Janssen Oncology; Merck; Nimbus Therapeutics; Novartis; Pfizer; Xencor
Research Funding - Aravive (Inst); ArsenalBio (Inst); Bristol-Myers Squibb; Pionyr (Inst)
 
Benjamin Maughan
Consulting or Advisory Role - Arcus Biosciences; Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Exelixis; Janssen Oncology; Lilly; Merck; Peloton Therapeutics; Pfizer; Sanofi; Telix Pharmaceuticals; Tempus; Xencor
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - AstraZeneca (Inst); Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche
 
Tobias Else
No Relationships to Disclose
 
Jodi Maranchie
Research Funding - Janssen (Inst); Merck (Inst); Protara Therapeutics (Inst)
Other Relationship - Elsevier
 
Ane Bundsbæk Bøndergaard Iversen
No Relationships to Disclose
 
Jerry Cornell
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Rodolfo Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Donna Vickery
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
W Linehan
No Relationships to Disclose
 
Eric Jonasch
Consulting or Advisory Role - Arcus Biosciences; Aveo; Eisai; Exelixis; GlaxoSmithKline; Ipsen; Merck; NiKang Therapeutics; Novartis; Takeda; Telix Pharmaceuticals
Research Funding - Abbvie (Inst); Aveo (Inst); Bristol Myers Squibb Foundation (Inst); Corvus Pharmaceuticals (Inst); Merck (Inst); NiKang Therapeutics (Inst); ProfoundBio (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Pfizer